Edition:
United Kingdom

People: Corcept Therapeutics Inc (CORT.OQ)

CORT.OQ on NASDAQ Stock Exchange Capital Market

11.00USD
19 Jul 2019
Change (% chg)

$0.08 (+0.73%)
Prev Close
$10.92
Open
$10.88
Day's High
$11.08
Day's Low
$10.83
Volume
188,678
Avg. Vol
244,288
52-wk High
$19.48
52-wk Low
$9.14

Grauer, Andreas 

Dr. Andreas Grauer, M.D., is Chief Medical Officer of the Company.He has served as our Chief Medical Officer since March 2019. Prior to joining Corcept, Dr. Grauer spent more than ten years at Amgen in a variety of leadership roles, most recently as Vice President of Global Development, where he led or oversaw programs in therapeutic areas including bone, nephrology, and inflammation throughout all phases of development. Dr. Grauer also brings significant experience in regulatory filings across the world that culminated in multiple new drug application and biologic license application approvals. Before Amgen, he held senior executive positions at Procter & Gamble Pharmaceuticals. Dr. Grauer holds an M.D. from the University of Heidelberg Medical School, where he graduated magna cum laude. He is Board Certified in both internal medicine and endocrinology in Germany.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

James Wilson

758,669

Joseph Belanoff

6,314,620

Gary Robb

2,845,670

Sean Maduck

2,806,070

Andreas Grauer

--

George Baker

267,889
As Of  31 Dec 2018